| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8567 |
| Human Intestinal Absorption | HIA+ | 0.9889 |
| Caco-2 Permeability | Caco2+ | 0.6351 |
| P-glycoprotein Substrate | Non-substrate | 0.8630 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9045 |
| Non-inhibitor | 0.9675 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8663 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5027 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8401 |
| CYP450 2D6 Substrate | Non-substrate | 0.8668 |
| CYP450 3A4 Substrate | Non-substrate | 0.7233 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9070 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7786 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8743 |
| Non-inhibitor | 0.8772 |
| AMES Toxicity | Non AMES toxic | 0.8999 |
| Carcinogens | Non-carcinogens | 0.8564 |
| Fish Toxicity | High FHMT | 0.5283 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9090 |
| Honey Bee Toxicity | Low HBT | 0.8488 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.6172 |
| Carcinogenicity (Three-class) | Non-required | 0.5299 |